Details for: PDGFA DT

Gene ID: 441307

Gene Type:  ncRNA (Non-coding RNA)  - A functional RNA molecule that is transcribed from DNA but not translated into a protein. Includes classes like miRNA and lncRNA.

Symbol: PDGFA DT

Ensembl ID: ENSG00000223855

Description: PDGFA divergent transcript

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • ciliated epithelial cell CL0000067
    CSI 3.78
    rCSI 3.33%
    PRS 99.3
  • cardiac muscle cell CL0000746
    CSI 2.36
    rCSI 3.38%
    PRS 99.22
  • regular ventricular cardiac myocyte CL0002131
    CSI 2.04
    rCSI 12.76%
    PRS 99.34
  • megakaryocyte CL0000556
    CSI 1.53
    rCSI 6.64%
    PRS 99.32
  • platelet CL0000233
    CSI 1.39
    rCSI 5.77%
    PRS 98.96

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [PDGFA DT](/details-gene/441307) (Platelet-derived growth factor alpha divergent transcript) is a non-coding RNA located on human chromosome 7p22.3. As a divergent transcript, it originates from the promoter region of the well-characterized protein-coding gene, [PDGFA](/details-gene/5154), suggesting a potential *cis*-regulatory relationship. **Overall**, its expression profile indicates high significance in specific cell populations, most notably in [ciliated epithelial cell](/details-cell/CL0000067) (CSI: 3.78). It also shows significant expression in [cardiac muscle cell](/details-cell/CL0000746)s and cells of the megakaryocytic lineage, including [megakaryocyte](/details-cell/CL0000556)s and [platelet](/details-cell/CL0000233)s, pointing towards specialized roles in diverse physiological systems. ## Cellular Roles and Expression Landscape The expression pattern of [PDGFA DT](/details-gene/441307) highlights its potential function in distinct and functionally diverse cell types. Its highest significance is observed in [ciliated epithelial cell](/details-cell/CL0000067), suggesting a potential involvement in the biology of mucosal surfaces, such as those in the respiratory or reproductive tracts, where ciliary function is critical. A second prominent site of expression is the cardiovascular system, with high significance scores in both general [cardiac muscle cell](/details-cell/CL0000746)s (CSI: 2.36) and more specifically in [regular ventricular cardiac myocyte](/details-cell/CL0002131)s (CSI: 2.04). This consistent signal within the cardiac lineage suggests a role in myocardial development, function, or homeostasis. Finally, [PDGFA DT](/details-gene/441307) is significantly expressed in the hematopoietic system, specifically within the lineage responsible for thrombosis and hemostasis. Its presence in both precursor [megakaryocyte](/details-cell/CL0000556)s (CSI: 1.53) and terminal [platelet](/details-cell/CL0000233)s (CSI: 1.39) indicates a possible role in thrombopoiesis or the regulation of platelet function. The collective expression profile points to a highly specialized, rather than ubiquitous, role for this non-coding RNA. ## Pathways and Molecular Function As a non-coding RNA, [PDGFA DT](/details-gene/441307) does not produce a protein but likely functions at the RNA level to regulate gene expression. Its genomic position, transcribed divergently from the [PDGFA](/details-gene/5154) promoter, strongly implies a primary function in modulating the expression of this key growth factor. The PDGF signaling pathway is critical for cellular proliferation, differentiation, and migration in many developmental and physiological processes. Therefore, the cell-specific expression of [PDGFA DT](/details-gene/441307) is consistent with it acting as a local regulator of the PDGF pathway in specific contexts. In [cardiac muscle cell](/details-cell/CL0000746)s, it may fine-tune [PDGFA](/details-gene/5154) expression to control cardiomyocyte growth and survival. In [megakaryocyte](/details-cell/CL0000556)s, it could influence the differentiation signals required for platelet formation. In [ciliated epithelial cell](/details-cell/CL0000067)s, it might regulate local tissue maintenance and repair processes mediated by PDGFA. The precise molecular mechanism, whether through transcriptional enhancement, repression, or chromatin remodeling, remains to be elucidated. ## Research Directions The specific expression patterns of [PDGFA DT](/details-gene/441307) and its putative link to the critical [PDGFA](/details-gene/5154) signaling pathway provide a foundation for several testable hypotheses and potential therapeutic exploration. **Proposed Hypotheses:** 1. [PDGFA DT](/details-gene/441307) acts as a *cis*-acting transcriptional enhancer of the [PDGFA](/details-gene/5154) gene in [cardiac muscle cell](/details-cell/CL0000746)s, and its dysregulation contributes to pathological cardiac remodeling. 2. The expression of [PDGFA DT](/details-gene/441307) is essential for the terminal differentiation of [megakaryocyte](/details-cell/CL0000556)s into functional [platelet](/details-cell/CL0000233)s, potentially by controlling the timing or level of [PDGFA](/details-gene/5154) signaling during thrombopoiesis. 3. In [ciliated epithelial cell](/details-cell/CL0000067)s of the airway, [PDGFA DT](/details-gene/441307) expression is induced upon injury and mediates epithelial repair by modulating local [PDGFA](/details-gene/5154) activity. **Key Experimental Approach:** To test the hypothesis that [PDGFA DT](/details-gene/441307) regulates [PDGFA](/details-gene/5154) expression in cardiac cells (Hypothesis 1), a targeted knockdown approach could be employed. Specifically, one could use antisense oligonucleotides (ASOs) or a CRISPR interference (CRISPRi) system to specifically degrade or repress [PDGFA DT](/details-gene/441307) in a culture of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Subsequent analysis using quantitative PCR (qPCR) and Western blotting would determine if the loss of the non-coding RNA leads to a corresponding decrease in [PDGFA](/details-gene/5154) mRNA and protein levels, thus establishing a direct regulatory link in a physiologically relevant cell type. **Therapeutic Potential:** The potential of [PDGFA DT](/details-gene/441307) as a therapeutic target lies in its specificity. The PDGF pathway is often dysregulated in diseases such as fibrosis and cancer, but systemic inhibition of PDGFA can have significant side effects. Because [PDGFA DT](/details-gene/441307) appears to be expressed in a highly cell-type-specific manner, it represents a candidate for targeted inhibition. Therapeutic modalities like ASOs could be developed to specifically reduce its expression in target tissues (e.g., the heart in cardiac fibrosis), thereby downregulating the local activity of the PDGF pathway with potentially greater precision and fewer off-target effects than direct protein inhibitors.